Of the 258 participants, 195 were cognitively asymptomatic, 34 had mild cognitive impairment, 23 had dementia, and six had an ...

What if you could detect Alzheimer's before symptoms even start? Researchers are racing against the clock to find a way. A ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

The global frontotemporal dementia management market is estimated to be valued at USD 396.1 million in 2025 and is forecast to grow to USD 626.4 million by 2035, advancing at a CAGR of 4.7% during the ...

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Amyloid, a naturally occurring protein, can accumulate ...

Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a ...

The team used a special type of brain scan called tau PET, which tracks a protein known as tau that builds up in the brain ...

USC researchers have found a promising new brain scan marker that could better detect Alzheimer’s risk — but only for some.

This new study takes a deeper look at how some of those modifiable risks actually affect Alzheimer’s disease at a biological ...